BioWorld MedTech

April 18, 2016

Vertos prods CMS for another look at national coverage decision of PILD

Vertos Medical Inc. has requested that the CMS reopen a national coverage decision after only two years, a move that could open the procedure up to millions of Medicare beneficiaries in the years ahead. Read More

Illumina commits $100M to new VC firm founded by former company exec

SEM Scanner set to ease the pressure in the Canadian wound care market

Elekta bets future on game-changer in radiotherapy

Other News to Note

Daily M&A

Financings

Regulatory Front

Keeping you up to date on recent developments in neurology

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...